Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302
Condition(s):Paroxysmal Supraventricular TachycardiaLast Updated:April 24, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Paroxysmal Supraventricular TachycardiaLast Updated:April 24, 2023Terminated
Condition(s):Paroxysmal Supraventricular TachycardiaLast Updated:February 15, 2024Completed
Condition(s):Aortic DiseasesLast Updated:December 4, 2013Completed
Condition(s):Acute Ischemic StrokeLast Updated:August 1, 2023Completed
Condition(s):Blood PressureLast Updated:June 28, 2022Not yet recruiting
Condition(s):Kidney, Polycystic, Autosomal DominantLast Updated:October 18, 2007Unknown status
Condition(s):HypertensionLast Updated:February 20, 2024Completed
Condition(s):Systemic Sclerosis; Cardiac Diseases; Heart Block; Cardiac Arrhythmia; Congestive Heart FailureLast Updated:November 8, 2013Unknown status
Condition(s):Renal CalculiLast Updated:October 6, 2010Unknown status
Condition(s):Essential HypertensionLast Updated:April 29, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.